CompaniesHemera Biosciences

Hemera Biosciences

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

By Phase

PHASE2: 1

By Status

WITHDRAWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
NCT04358471
Hover over trial bars to see details

Recent Trials

NCT04358471Lead Sponsor
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
PHASE2Withdrawn
Started: Jul 31, 2021 · Completed: Sep 1, 2023
Funding History (1)
D
Apr 1, 2013
Filing
Related Companies
Janssen
acquired